Clinical Trial Update: Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating preoperative immunotherapy combined with stereotactic radiation therapy for HER2-negative breast cancer, with recruitment ongoing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING